Dr. Hamed Ahmadi, MD
Claim this profileUniversity of Minnesota
Studies Bladder Cancer
Studies Radical Cystectomy
4 reported clinical trials
6 drugs studied
Area of expertise
1Bladder Cancer
Stage I
Stage II
Stage III
2Radical Cystectomy
Stage III
Affiliated Hospitals
Clinical Trials Hamed Ahmadi, MD is currently running
ONCOFID-P-B
for Bladder Cancer
This trial tests ONCOFID-P-B, a bladder-inserted medication, in adults with certain types of bladder cancer who did not respond to standard treatment and cannot or do not want surgery. The treatment aims to directly target and kill cancer cells in the bladder. ONCOFID-P-B is a new compound developed by Fidia Farmaceutici S.p.A. with specific binding to the CD44 receptor, showing high safety and effectiveness in patients with bladder cancer that did not respond to previous treatments.
Recruiting2 awards Phase 314 criteria
Prophylactic Antibiotics
for Bladder Cancer
Using a randomized 2 arm design, this study is being conducted to test for non-inferiority of no prophylactic antibiotic therapy versus the prophylactic oral antibiotic, nitrofurantoin, through comparison of rates of postoperative urinary tract infections within the 90-day postoperative period in patients with muscle invasive bladder cancer who undergo radical cystectomy with urinary diversion.
Recruiting1 award Phase < 1
More about Hamed Ahmadi, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Hamed Ahmadi, MD has experience with
- Nitrofurantoin
- ONCOFID P-B (PACLITAXEL-HYALURONIC ACID)
- Cxbladder
- Bacillus Calmette Guerin
- Docetaxel
- Gemcitabine
Breakdown of trials Hamed Ahmadi, MD has run
Bladder Cancer
Radical Cystectomy
Ileal Conduit
Bladder reconstruction
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hamed Ahmadi, MD specialize in?
Hamed Ahmadi, MD focuses on Bladder Cancer and Radical Cystectomy. In particular, much of their work with Bladder Cancer has involved Stage I patients, or patients who are Stage II.
Is Hamed Ahmadi, MD currently recruiting for clinical trials?
Yes, Hamed Ahmadi, MD is currently recruiting for 3 clinical trials in Minneapolis Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Hamed Ahmadi, MD has studied deeply?
Yes, Hamed Ahmadi, MD has studied treatments such as Nitrofurantoin, ONCOFID P-B (PACLITAXEL-HYALURONIC ACID), Cxbladder.
What is the best way to schedule an appointment with Hamed Ahmadi, MD?
Apply for one of the trials that Hamed Ahmadi, MD is conducting.
What is the office address of Hamed Ahmadi, MD?
The office of Hamed Ahmadi, MD is located at: University of Minnesota, Minneapolis, Minnesota 55455 United States. This is the address for their practice at the University of Minnesota.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.